Concord Biotech Ltd
CONCORDBIO
Pharmaceuticals
₹ 1,667
Price
₹ 17,420
Market Cap
Mid Cap
53.07
P/E Ratio
📊 Score Snapshot
18.28 / 25
Performance
16.85 / 25
Valuation
1.97 / 20
Growth
7.0 / 30
Profitability
44.1 / 100
Risky
🏢 Company Overview
⏳ Loading company overview...
🤖 CARL Insights
⏳ Loading CARL insights...
📈 Net Profit (Yearly)
📊 Sales (Yearly)
📉 Quarterly Sales Trend
📉 Quarterly Net Profit
📈 Yearly Ratios
| Metric | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|
| Adj Cash EBITDA | 370.70 | 323.59 | 270.19 | 245.82 | 189.92 | - | 139.92 |
| Adj Cash EBITDA Margin | 39.52 | 39.95 | 40.94 | 39.46 | 39.40 | - | 41.15 |
| Adj Cash EBITDA To EBITDA | 0.82 | 0.86 | 0.92 | 0.73 | 0.90 | - | 0.86 |
| Adj Cash EPS | 22.40 | - | - | - | - | - | - |
| Adj Cash PAT | 234.50 | 188.69 | 160.86 | 151.25 | 165.61 | - | 77.00 |
| Adj Cash PAT To PAT | 0.74 | 0.78 | 0.88 | 0.63 | 0.88 | - | 0.77 |
| Adj Cash PE | 69.71 | - | - | - | - | - | - |
| Adj EPS | 30.13 | - | - | - | - | - | - |
| Adj EV To Cash EBITDA | 41.27 | - | - | - | - | - | - |
| Adj EV To EBITDA | 33.87 | - | - | - | - | - | - |
| Adj Number Of Shares | 10.47 | - | - | - | - | - | - |
| Adj PE | 51.17 | - | - | - | - | - | - |
| Bvps | 145.65 | - | - | - | - | - | - |
| Cash Conversion Cycle | 306.00 | 357.00 | 368.00 | 456.00 | 242.00 | 331.00 | 407.00 |
| Cash ROCE | 12.85 | 7.72 | 4.59 | -3.62 | -0.73 | - | - |
| Cash Roic | 12.80 | 5.51 | 3.35 | -4.28 | -1.67 | - | - |
| Cash Revenue | 938.00 | 810.00 | 660.00 | 623.00 | 482.00 | - | 340.00 |
| Cash Revenue To Revenue | 0.92 | 0.95 | 0.93 | 1.01 | 0.94 | - | 1.00 |
| Dio | 331.00 | 430.00 | 434.00 | 503.00 | 312.00 | 310.00 | 381.00 |
| Dpo | 150.00 | 190.00 | 185.00 | 152.00 | 201.00 | 112.00 | 210.00 |
| Dso | 125.00 | 117.00 | 119.00 | 105.00 | 131.00 | 133.00 | 236.00 |
| Dividend Yield | 0.59 | - | - | - | - | - | - |
| EV | 15,300 | - | - | - | - | - | - |
| EV To EBITDA | 34.96 | - | - | - | - | - | - |
| EV To Fcff | 90.60 | - | - | - | - | - | - |
| Fcfe | 177.50 | 68.69 | 28.86 | 13.25 | 69.61 | - | 90.00 |
| Fcfe Margin | 18.92 | 8.48 | 4.37 | 2.13 | 14.44 | - | 26.47 |
| Fcfe To Adj PAT | 0.56 | 0.29 | 0.16 | 0.06 | 0.37 | - | 0.90 |
| Fcff | 168.87 | 72.70 | 38.36 | -39.76 | -11.81 | - | 83.19 |
| Fcff Margin | 18.00 | 8.98 | 5.81 | -6.38 | -2.45 | - | 24.47 |
| Fcff To NOPAT | 0.60 | 0.34 | 0.23 | -0.18 | -0.08 | - | 0.94 |
| Market Cap | 15,581 | - | - | - | - | - | - |
| PB | 10.22 | - | - | - | - | - | - |
| PE | 51.09 | - | - | - | - | - | - |
| PS | 15.32 | - | - | - | - | - | - |
| ROCE | 20.75 | 19.19 | 15.92 | 24.10 | 20.01 | 17.86 | - |
| ROE | 22.40 | 20.06 | 17.35 | 27.13 | 25.81 | 18.70 | - |
| Roic | 21.37 | 16.34 | 14.53 | 24.23 | 20.48 | 16.39 | - |
| Share Price | 1,488 | - | - | - | - | - | - |
📊 Quarterly Results
| Metric | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 244.00 | 310.00 | 216.00 | 319.00 | 241.00 | 262.00 | 195.00 | 273.00 | 241.00 | 159.00 | 181.00 |
| Interest | - | - | - | - | - | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Expenses - | 146.00 | 174.00 | 135.00 | 185.00 | 135.00 | 143.00 | 123.00 | 144.00 | 129.00 | 121.00 | 116.00 |
| Other Income - | 14.73 | 10.03 | 10.31 | 10.81 | 8.19 | 8.13 | 6.65 | 12.20 | 9.25 | 6.03 | 7.83 |
| Depreciation | 13.00 | 13.00 | 13.00 | 14.00 | 14.00 | 13.00 | 13.00 | 14.00 | 14.00 | 13.00 | 14.00 |
| Profit Before Tax | 99.00 | 133.00 | 78.00 | 131.00 | 100.00 | 113.00 | 65.00 | 126.00 | 106.00 | 30.00 | 58.00 |
| Tax % | 25.25 | 25.56 | 25.64 | 25.95 | 25.00 | 25.66 | 26.15 | 25.40 | 25.47 | 26.67 | 25.86 |
| Net Profit - | 74.00 | 99.00 | 58.00 | 97.00 | 75.00 | 84.00 | 48.00 | 94.00 | 79.00 | 22.00 | 43.00 |
| Profit For PE | 74.00 | 99.00 | 58.00 | 97.00 | 75.00 | 84.00 | 48.00 | 94.00 | 79.00 | 22.00 | 43.00 |
| Profit For EPS | 74.00 | 99.00 | 58.00 | 97.00 | 75.00 | 84.00 | 48.00 | 94.00 | 79.00 | 22.00 | 43.00 |
| EPS In Rs | 7.08 | 9.43 | 5.57 | 9.29 | 7.13 | 8.08 | 4.63 | 8.94 | 7.56 | 2.14 | 45.32 |
| PAT Margin % | 30.33 | 31.94 | 26.85 | 30.41 | 31.12 | 32.06 | 24.62 | 34.43 | 32.78 | 13.84 | 23.76 |
| PBT Margin | 40.57 | 42.90 | 36.11 | 41.07 | 41.49 | 43.13 | 33.33 | 46.15 | 43.98 | 18.87 | 32.04 |
| Tax | 25.00 | 34.00 | 20.00 | 34.00 | 25.00 | 29.00 | 17.00 | 32.00 | 27.00 | 8.00 | 15.00 |
| Yoy Profit Growth % | -1.00 | 17.00 | 20.00 | 4.00 | -6.00 | 277.00 | 12.00 | - | - | - | - |
| Adj Ebit | 99.73 | 133.03 | 78.31 | 130.81 | 100.19 | 114.13 | 65.65 | 127.20 | 107.25 | 31.03 | 58.83 |
| Adj EBITDA | 112.73 | 146.03 | 91.31 | 144.81 | 114.19 | 127.13 | 78.65 | 141.20 | 121.25 | 44.03 | 72.83 |
| Adj EBITDA Margin | 46.20 | 47.11 | 42.27 | 45.39 | 47.38 | 48.52 | 40.33 | 51.72 | 50.31 | 27.69 | 40.24 |
| Adj Ebit Margin | 40.87 | 42.91 | 36.25 | 41.01 | 41.57 | 43.56 | 33.67 | 46.59 | 44.50 | 19.52 | 32.50 |
| Adj PAT | 74.00 | 99.00 | 58.00 | 97.00 | 75.00 | 84.00 | 48.00 | 94.00 | 79.00 | 22.00 | 43.00 |
| Adj PAT Margin | 30.33 | 31.94 | 26.85 | 30.41 | 31.12 | 32.06 | 24.62 | 34.43 | 32.78 | 13.84 | 23.76 |
| Ebit | 99.73 | 133.03 | 78.31 | 130.81 | 100.19 | 114.13 | 65.65 | 127.20 | 107.25 | 31.03 | 58.83 |
| EBITDA | 112.73 | 146.03 | 91.31 | 144.81 | 114.19 | 127.13 | 78.65 | 141.20 | 121.25 | 44.03 | 72.83 |
| EBITDA Margin | 46.20 | 47.11 | 42.27 | 45.39 | 47.38 | 48.52 | 40.33 | 51.72 | 50.31 | 27.69 | 40.24 |
| Ebit Margin | 40.87 | 42.91 | 36.25 | 41.01 | 41.57 | 43.56 | 33.67 | 46.59 | 44.50 | 19.52 | 32.50 |
| NOPAT | 63.54 | 91.56 | 50.56 | 88.86 | 69.00 | 78.80 | 43.57 | 85.79 | 73.04 | 18.33 | 37.81 |
| NOPAT Margin | 26.04 | 29.54 | 23.41 | 27.86 | 28.63 | 30.08 | 22.34 | 31.42 | 30.31 | 11.53 | 20.89 |
| Operating Profit | 85.00 | 123.00 | 68.00 | 120.00 | 92.00 | 106.00 | 59.00 | 115.00 | 98.00 | 25.00 | 51.00 |
| Operating Profit Margin | 34.84 | 39.68 | 31.48 | 37.62 | 38.17 | 40.46 | 30.26 | 42.12 | 40.66 | 15.72 | 28.18 |
💰 Profit & Loss
| Metric | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|
| Sales | 1,017 | 853.00 | 713.00 | 617.00 | 512.00 | 436.00 | 340.00 |
| Interest | 3.00 | 5.00 | 6.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Expenses - | 585.00 | 509.00 | 439.00 | 289.00 | 308.00 | 256.00 | 195.00 |
| Other Income - | 19.70 | 31.59 | 18.19 | 6.82 | 7.92 | 15.15 | 17.92 |
| Exceptional Items | 14.08 | 3.62 | 5.20 | 6.99 | 23.45 | 2.29 | - |
| Depreciation | 54.00 | 54.00 | 50.00 | 28.00 | 21.00 | 19.00 | 18.00 |
| Profit Before Tax | 409.00 | 320.00 | 241.00 | 313.00 | 213.00 | 178.00 | 144.00 |
| Tax % | 25.43 | 25.62 | 25.73 | 24.92 | 20.66 | 33.71 | 30.56 |
| Net Profit - | 305.00 | 238.00 | 179.00 | 235.00 | 169.00 | 118.00 | 100.00 |
| Exceptional Items At | 10.00 | 3.00 | 4.00 | 5.00 | 17.00 | 2.00 | - |
| Profit For PE | 294.00 | 235.00 | 175.00 | 230.00 | 151.00 | 117.00 | 100.00 |
| Profit For EPS | 305.00 | 238.00 | 179.00 | 235.00 | 169.00 | 118.00 | 100.00 |
| EPS In Rs | 29.13 | - | - | - | - | - | - |
| Dividend Payout % | 30.00 | 30.00 | 3.00 | - | 22.00 | 21.00 | - |
| PAT Margin % | 29.99 | 27.90 | 25.11 | 38.09 | 33.01 | 27.06 | 29.41 |
| PBT Margin | 40.22 | 37.51 | 33.80 | 50.73 | 41.60 | 40.83 | 42.35 |
| Tax | 104.00 | 82.00 | 62.00 | 78.00 | 44.00 | 60.00 | 44.00 |
| Adj Ebit | 397.70 | 321.59 | 242.19 | 306.82 | 190.92 | 176.15 | 144.92 |
| Adj EBITDA | 451.70 | 375.59 | 292.19 | 334.82 | 211.92 | 195.15 | 162.92 |
| Adj EBITDA Margin | 44.41 | 44.03 | 40.98 | 54.27 | 41.39 | 44.76 | 47.92 |
| Adj Ebit Margin | 39.11 | 37.70 | 33.97 | 49.73 | 37.29 | 40.40 | 42.62 |
| Adj PAT | 315.50 | 240.69 | 182.86 | 240.25 | 187.61 | 119.52 | 100.00 |
| Adj PAT Margin | 31.02 | 28.22 | 25.65 | 38.94 | 36.64 | 27.41 | 29.41 |
| Ebit | 383.62 | 317.97 | 236.99 | 299.83 | 167.47 | 173.86 | 144.92 |
| EBITDA | 437.62 | 371.97 | 286.99 | 327.83 | 188.47 | 192.86 | 162.92 |
| EBITDA Margin | 43.03 | 43.61 | 40.25 | 53.13 | 36.81 | 44.23 | 47.92 |
| Ebit Margin | 37.72 | 37.28 | 33.24 | 48.59 | 32.71 | 39.88 | 42.62 |
| NOPAT | 281.87 | 215.70 | 166.36 | 225.24 | 145.19 | 106.73 | 88.19 |
| NOPAT Margin | 27.72 | 25.29 | 23.33 | 36.51 | 28.36 | 24.48 | 25.94 |
| Operating Profit | 378.00 | 290.00 | 224.00 | 300.00 | 183.00 | 161.00 | 127.00 |
| Operating Profit Margin | 37.17 | 34.00 | 31.42 | 48.62 | 35.74 | 36.93 | 37.35 |
🏦 Balance Sheet
| Metric | Sep 2024 | Mar 2024 | Sep 2023 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | - | 250.20 | - | 198.71 | 146.97 | 98.08 | 70.55 | 51.21 | 32.24 |
| Advance From Customers | - | 4.00 | - | 2.00 | 12.00 | 3.00 | 20.00 | 1.00 | - |
| Average Capital Employed | 1,486 | 1,429 | - | 1,246 | 1,130 | 956.00 | 757.00 | 654.00 | - |
| Average Invested Capital | 1,359 | 1,319 | - | 1,320 | 1,145 | 929.50 | 709.00 | 651.00 | - |
| Average Total Assets | 1,658 | 1,607 | - | 1,414 | 1,248 | 1,062 | 852.00 | 724.00 | - |
| Average Total Equity | 1,472 | 1,408 | - | 1,200 | 1,054 | 885.50 | 727.00 | 639.00 | - |
| Cwip | 249.00 | 211.00 | 188.00 | 173.00 | 74.00 | 18.00 | 141.00 | 19.00 | 3.00 |
| Capital Employed | 1,595 | 1,535 | 1,376 | 1,323 | 1,170 | 1,089 | 823.00 | 691.00 | 617.00 |
| Cash Equivalents | 8.00 | 47.00 | 75.00 | 43.00 | 89.00 | 61.00 | 3.00 | 4.00 | 2.00 |
| Fixed Assets | 558.00 | 575.00 | 590.00 | 593.00 | 573.00 | 546.00 | 240.00 | 230.00 | 189.00 |
| Gross Block | - | 825.51 | - | 791.69 | 719.94 | 644.29 | 310.15 | 280.91 | 220.92 |
| Inventory | 250.00 | 208.00 | 220.00 | 212.00 | 195.00 | 154.00 | 111.00 | 92.00 | 71.00 |
| Invested Capital | 1,300 | 1,229 | 1,418 | 1,409 | 1,231 | 1,059 | 800.00 | 618.00 | 684.00 |
| Investments | 276.00 | 244.00 | 151.00 | 138.00 | 74.00 | 142.00 | 199.00 | 229.00 | 151.00 |
| Lease Liabilities | 3.43 | 3.51 | 4.24 | 0.31 | 1.91 | 2.93 | 4.02 | - | - |
| Loans N Advances | 9.00 | 15.00 | - | 7.00 | 7.00 | 6.00 | 6.00 | - | - |
| Long Term Borrowings | - | - | - | 6.24 | 31.25 | 56.25 | 35.53 | - | - |
| Net Debt | -281.00 | -281.00 | -203.00 | -149.00 | -101.00 | -114.00 | -150.00 | -224.00 | -131.00 |
| Net Working Capital | 493.00 | 443.00 | 640.00 | 643.00 | 584.00 | 495.00 | 419.00 | 369.00 | 492.00 |
| Other Asset Items | 69.00 | 49.00 | 60.00 | 75.00 | 68.00 | 79.00 | 58.00 | 31.00 | 49.00 |
| Other Borrowings | - | - | - | - | - | - | 12.51 | 9.22 | 22.21 |
| Other Liability Items | 88.00 | 66.00 | 98.00 | 96.00 | 48.00 | 45.00 | 27.00 | 38.00 | 29.00 |
| Reserves | 1,580 | 1,515 | 1,343 | 1,282 | 1,098 | 990.00 | 761.00 | 673.00 | 585.00 |
| Share Capital | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Short Term Borrowings | - | 6.23 | 18.73 | 25.00 | 29.34 | 30.10 | - | - | - |
| Total Assets | 1,765 | 1,699 | 1,550 | 1,515 | 1,313 | 1,183 | 941.00 | 763.00 | 685.00 |
| Total Borrowings | 3.00 | 10.00 | 23.00 | 32.00 | 62.00 | 89.00 | 52.00 | 9.00 | 22.00 |
| Total Equity | 1,590 | 1,525 | 1,353 | 1,292 | 1,108 | 1,000 | 771.00 | 683.00 | 595.00 |
| Total Equity And Liabilities | 1,765 | 1,699 | 1,550 | 1,515 | 1,313 | 1,183 | 941.00 | 763.00 | 685.00 |
| Total Liabilities | 175.00 | 174.00 | 197.00 | 223.00 | 205.00 | 183.00 | 170.00 | 80.00 | 90.00 |
| Trade Payables | 82.00 | 94.00 | 76.00 | 94.00 | 83.00 | 46.00 | 71.00 | 33.00 | 39.00 |
| Trade Receivables | 344.00 | 350.00 | 534.00 | 548.00 | 464.00 | 356.00 | 368.00 | 318.00 | 440.00 |
💵 Cash Flows
| Metric | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2018 |
|---|---|---|---|---|---|---|
| Cash From Financing Activity | -99.00 | -85.00 | -100.00 | 31.00 | -43.00 | -37.00 |
| Cash From Investing Activity | -155.00 | -158.00 | -112.00 | -195.00 | -114.00 | -42.00 |
| Cash From Operating Activity | 265.00 | 246.00 | 207.00 | 167.00 | 155.00 | 79.00 |
| Cash Paid For Purchase Of Fixed Assets | -86.00 | -145.00 | -156.00 | -204.00 | -156.00 | - |
| Cash Paid For Purchase Of Investments | -838.00 | -643.00 | -489.00 | -618.00 | -481.00 | - |
| Cash Paid For Repayment Of Borrowings | -25.00 | -29.00 | -26.00 | -19.00 | -9.00 | -5.00 |
| Cash Received From Borrowings | - | - | - | 57.00 | 48.00 | - |
| Cash Received From Sale Of Investments | 746.00 | 583.00 | 561.00 | 682.00 | 524.00 | - |
| Change In Inventory | 4.00 | -17.00 | -42.00 | -42.00 | -20.00 | -10.00 |
| Change In Other Working Capital Items | 4.00 | -2.00 | 36.00 | -30.00 | -12.00 | -13.00 |
| Change In Payables | -11.00 | 10.00 | 37.00 | -23.00 | 39.00 | - |
| Change In Receivables | -79.00 | -43.00 | -53.00 | 6.00 | -30.00 | - |
| Change In Working Capital | -81.00 | -52.00 | -22.00 | -89.00 | -22.00 | -23.00 |
| Direct Taxes Paid | -103.00 | -70.00 | -61.00 | -75.00 | -49.00 | -50.00 |
| Dividends Paid | -71.00 | -54.00 | -71.00 | -6.00 | -81.00 | -31.00 |
| Interest Paid | -3.00 | -4.00 | -5.00 | - | - | -1.00 |
| Interest Received | 3.00 | 6.00 | 4.00 | - | - | - |
| Net Cash Flow | 12.00 | 3.00 | -4.00 | 3.00 | -1.00 | - |
| Other Cash Financing Items Paid | -1.00 | 1.00 | 1.00 | -1.00 | - | - |
| Other Cash Investing Items Paid | 21.00 | 41.00 | -33.00 | -55.00 | - | -42.00 |
| Profit From Operations | 450.00 | 369.00 | 290.00 | 331.00 | 226.00 | 152.00 |
🧾 Shareholding Pattern
| Nse Code | Date | Promoters | Fii | Dii | Public | Others |
|---|---|---|---|---|---|---|
| Concordbio | 2024-12-31 | - | 8.33 | 9.65 | 37.93 | 0.00 |
| Concordbio | 2024-09-30 | - | 8.10 | 9.82 | 38.02 | 0.00 |
| Concordbio | 2024-06-30 | - | 7.11 | 10.35 | 38.46 | 0.00 |
| Concordbio | 2024-03-31 | - | 6.49 | 8.41 | 41.03 | 0.00 |
💬
Stock Chat